Phase-II Trial of Induction Chemotherapy and Chemoradiotherapy Plus/Minus Durvalumab and Consolidation Immunotherapy in Patients With Resectable Stage III NSCLC.
Clinical trial NCT04202809 · UNKNOWN
Trial details
- NCT number
- NCT04202809
- Sponsor
- University Hospital, Essen
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-13
- Primary completion
- 2025-04-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.